Title: | Phase I study of stereotactic body radiation therapy for peripheral T2N0M0 non-small cell lung cancer with PTV < 100 cc using a continual reassessment method (JCOG0702) |
Authors: | Onimaru, Rikiya Browse this author →KAKEN DB |
Shirato, Hiroki Browse this author →KAKEN DB |
Shibata, Taro Browse this author |
Hiraoka, Masahiro Browse this author →KAKEN DB |
Ishikura, Satoshi Browse this author |
Karasawa, Katsuyuki Browse this author |
Matsuo, Yukinori Browse this author →KAKEN DB |
Kokubo, Masaki Browse this author →KAKEN DB |
Shioyama, Yoshiyuki Browse this author →KAKEN DB |
Matsushita, Haruo Browse this author →KAKEN DB |
Ito, Yoshinori Browse this author |
Onishi, Hiroshi Browse this author →KAKEN DB |
Keywords: | Phase I study |
Continual reassessment method |
Non-small cell lung cancer (NSCLC) |
Stereotactic body radiotherapy |
SBRT |
Issue Date: | Aug-2015 |
Publisher: | Elsevier |
Journal Title: | Radiotherapy and oncology |
Volume: | 116 |
Issue: | 2 |
Start Page: | 276 |
End Page: | 280 |
Publisher DOI: | 10.1016/j.radonc.2015.07.008 |
PMID: | 26233591 |
Abstract: | Purpose: To estimate the maximum tolerated dose (MTD) and to determine the recommended dose (RD) of stereotactic body radiation therapy (SBRT) for peripheral T2N0M0 non-small cell carcinoma (NSCLC) with target volume (PTV) < 100 cc. Materials and methods: The continual reassessment method (CRM) was used to determine the dose level that patients should be assigned to and to estimate the MTD. Dose limiting toxicity (DLT) was grade 3 radiation pneumonitis (RP) within 180 days after the start of SBRT, grade 2 RP was used as a surrogate DLT. The RD was equal to the MTD. The dose was prescribed at D95 of the PTV. Results: Fifteen patients were accrued. Only 1 experienced grade 2 RP at 60 Gy in 4 fractions. It was difficult to fulfill the dose constraints at 60 Gy in 4 fractions, and the maximum dose level assigned by CRM was changed to 55 Gy in 4 fractions. The lower limit of 95% of the credible interval exceeded the adjacent level, and the RD was determined as 55 Gy in 4 fractions. Conclusions: The RD of SBRT for peripheral T2N0M0 NSCLC with PTV < 100 cc was determined to be 55 Gy in 4 fractions. |
Rights: | © 2015, Elsevier. This manuscript version is made available under the CC-BY-NC-ND 4.0 license http://creativecommons.org/licenses/by-nc-nd/4.0/ |
http://creativecommons.org/licenses/by-nc-nd/4.0/ |
Type: | article (author version) |
URI: | http://hdl.handle.net/2115/62578 |
Appears in Collections: | 国際連携研究教育局 : GI-CoRE (Global Institution for Collaborative Research and Education : GI-CoRE) > 雑誌発表論文等 (Peer-reviewed Journal Articles, etc) 医学院・医学研究院 (Graduate School of Medicine / Faculty of Medicine) > 雑誌発表論文等 (Peer-reviewed Journal Articles, etc)
|